Ventilators did not kill COVID-19 patients as a rule, but the reality is more complicated than a simple yes or no. Mechanical ventilation carried serious risks that contributed to death in some cases, particularly during the early months of the pandemic when doctors faced an unfamiliar disease, hospitals were overwhelmed, and clinical guidelines were still taking shape. The extremely high mortality rates among ventilated patients in early 2020 reflected a combination of factors: the severity of the disease itself, complications from ventilation, secondary infections, and strained hospital resources.
Early Mortality Rates Were Alarming
During the first wave in New York City, between March and April 2020, 28-day mortality among intubated COVID-19 patients ranged from 57% to 65% depending on the type of ICU. That means more than half of patients placed on ventilators in those early months did not survive. Similar figures emerged from hospitals in Wuhan and northern Italy. These numbers fueled widespread suspicion that ventilators themselves were doing the harm.
But context matters. The patients who ended up on ventilators were already the sickest. COVID-19 caused a particularly aggressive form of acute respiratory distress syndrome (ARDS), where the lungs filled with fluid and inflammatory debris, making gas exchange nearly impossible. By the time someone needed a ventilator, their lungs were often severely damaged. Many of these patients would have died without mechanical ventilation. The ventilator was a last resort for people who could no longer breathe on their own.
How Ventilators Can Cause Harm
That said, mechanical ventilation is not a gentle therapy. It forces air into damaged lungs under pressure, and that pressure can cause real injury. In COVID-19 patients, a complication called barotrauma was frequent. When air pressure inside the lungs exceeds what fragile, inflamed tissue can handle, the tiny air sacs (alveoli) rupture. Air then leaks into spaces where it doesn’t belong: the chest cavity, the tissue around the heart, under the skin, even into the abdomen. This cascade of air leaks can be life-threatening on its own.
Research published in Clinical Imaging identified barotrauma as a frequent complication in mechanically ventilated COVID-19 patients. The already-damaged COVID lung was especially vulnerable to this kind of pressure injury. In early 2020, some clinicians used ventilator settings that may have been too aggressive for the unique characteristics of COVID pneumonia, though this was based on the best available knowledge at the time.
Secondary Infections Were a Major Factor
One of the biggest dangers for any patient on a ventilator is infection. A breathing tube bypasses the body’s natural defenses against bacteria, creating a direct path into the lungs. In COVID-19 patients, the rate of ventilator-associated pneumonia (VAP) was staggering. Studies found that anywhere from 25% to 85% of ventilated COVID patients developed bacterial pneumonia on top of their viral illness. That rate was roughly double what doctors typically see in non-COVID patients with respiratory failure.
In one single-center study, 73% of ventilated COVID patients developed VAP, and 14% went on to develop lung abscesses. A large multicenter study in the United Kingdom found that over 70% of hospitalized COVID patients developed secondary infections at least 48 hours after admission. About one in five of these secondary infections involved bacteria that were particularly difficult to treat with standard antibiotics. These infections compounded the lung damage already caused by the virus and significantly worsened survival odds.
COVID patients often spent far longer on ventilators than typical ARDS patients, sometimes weeks. Every additional day on a ventilator increases infection risk. The prolonged ventilation times, combined with overtaxed infection control during surges, created ideal conditions for hospital-acquired infections to take hold.
Overwhelmed Hospitals Changed Outcomes
Staffing played an underappreciated role. Research on ICU outcomes has consistently shown that hospitals with fewer nurses per patient have significantly higher mortality rates among ventilated patients. One analysis found that patients in hospitals with the lowest nurse staffing levels had more than twice the odds of dying compared to those in well-staffed hospitals.
During the early pandemic surges, this became a crisis within a crisis. Hospitals converted conference rooms, operating suites, and recovery areas into makeshift ICUs. Nurses trained in other specialties were reassigned to manage ventilators they had limited experience with. The New York City data showed this directly: mortality was 57% in traditional ICUs but rose to 65% in these expanded, improvised units staffed by less experienced teams. Ventilator management requires constant, skilled adjustment. When one nurse is monitoring six or eight critically ill patients instead of one or two, the quality of that management inevitably suffers.
How Treatment Evolved Over Time
One of the most important shifts was learning when not to intubate. In the earliest weeks, some hospitals moved quickly to place patients on ventilators when their oxygen levels dropped, partly out of concern that less invasive oxygen delivery methods (like nasal cannulas and face masks) would spray virus-laden aerosols into the air, endangering healthcare workers. This meant some patients were intubated earlier than may have been necessary.
As doctors gained experience, they discovered that many COVID patients could maintain adequate oxygen levels with less invasive approaches. High-flow nasal cannula (HFNC) oxygen, which delivers warm, humidified air at high rates through a simple nasal device, kept many patients off ventilators entirely. Awake prone positioning, where conscious patients lie face-down to improve oxygen distribution in their lungs, also proved valuable. One randomized trial of 400 patients found that combining prone positioning with high-flow oxygen reduced intubation rates from about 40% to 34%, and subgroup analyses suggested the benefit was even stronger for patients already receiving HFNC.
NIH treatment guidelines, first issued in April 2020, were updated repeatedly as evidence accumulated. The recommendations shifted toward exhausting non-invasive options before resorting to intubation. For most adults, the target oxygen saturation was set at 92% to 96%, and clinicians were advised to try high-flow oxygen and prone positioning before considering a ventilator. Medications like corticosteroids, which reduced the inflammatory lung damage driving respiratory failure, also decreased the number of patients who ever needed mechanical ventilation in the first place.
What Actually Killed These Patients
The honest answer is that COVID-19 killed these patients, and ventilators were an imperfect tool used to keep them alive long enough for their bodies to recover. In some cases, the complications of ventilation, including pressure injuries and secondary infections, contributed to or hastened death. In other cases, patients were intubated too early or managed with settings that were too aggressive for the type of lung damage COVID caused. And in surge conditions, the lack of experienced staff meant that even appropriate ventilator use couldn’t be optimized.
None of this means ventilators were the wrong choice. For patients in true respiratory failure, with oxygen levels incompatible with life, there was no alternative. The high death rates reflected the severity of the disease and the extraordinary circumstances of a global pandemic, not a medical system choosing a harmful treatment. As understanding improved, ventilation practices were refined, intubation rates dropped, and survival among those who did require ventilators improved substantially. The story of ventilators in COVID is less about a treatment that killed and more about a medical community learning in real time how to manage a disease no one had seen before.